Literature DB >> 3271007

A novel biologically active selenoorganic compound. VIII. Biotransformation of ebselen.

H Fischer1, R Terlinden, J P Löhr, A Römer.   

Abstract

1. The metabolism of ebselen, a Se-containing heterocyclic compound, in rats, pigs and human volunteers has been investigated. 2. Unchanged ebselen is not present in urine, plasma or bile. All metabolites of ebselen have in common that the isoselenazolone ring is opened. 3. Both in pigs and human, the dominant metabolite in plasma and urine is a Se-glucuronide. This is the major metabolite in rats as well but, additionally, some selenomethyl-derivatives of ebselen can be detected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3271007     DOI: 10.3109/00498258809042259

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

Review 1.  The pharmacology of ebselen.

Authors:  M J Parnham; S Leyck; E Graf; E J Dowling; D R Blake
Journal:  Agents Actions       Date:  1991-01

2.  Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.

Authors:  Nisha Singh; Ann L Sharpley; Uzay E Emir; Charles Masaki; Mohammad M Herzallah; Mark A Gluck; Trevor Sharp; Catherine J Harmer; Sridhar R Vasudevan; Philip J Cowen; Grant C Churchill
Journal:  Neuropsychopharmacology       Date:  2015-11-23       Impact factor: 7.853

3.  Mitogenic activity of selenoorganic compounds in human peripheral blood leukocytes.

Authors:  J A Czyrski; A D Inglot
Journal:  Experientia       Date:  1991-01-15

4.  Antimalarial properties of ebselen.

Authors:  A M Hüther; Y Zhang; A Sauer; M J Parnham
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

Review 5.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

Review 6.  Drug antioxidant effects. A basis for drug selection?

Authors:  B Halliwell
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.